Product Jurisdiction; Change of Address and Telephone Number; Technical Amendment
Final Rule; Technical Amendment.
The Food and Drug Administration (FDA) is amending its regulations to reflect a change in the address and telephone number for the Office of Combination Products (OCP). This action is editorial in nature and is intended to improve the accuracy of the agency's regulations.
Table of Contents Back to Top
DATES: Back to Top
Effective Date: April 19, 2010.
FOR FURTHER INFORMATION CONTACT: Back to Top
John Barlow Weiner, Office of Combination Products, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5130, Silver Spring, MD 20993-0002, 301-796-8930. To confirm that this change of address and telephone number has occurred, please see our Web site at www.fda.gov/CombinationProducts/default.htm.
SUPPLEMENTARY INFORMATION: Back to Top
FDA is amending its regulations in 21 CFR part 3 to reflect a change in the address and telephone number for OCP. Publication of this document constitutes final action on this change under the Administrative Procedure Act (5 U.S.C. 553). Notice and public procedures are unnecessary because FDA is merely updating nonsubstantive content.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 3 is amended as follows:
PART 3—PRODUCT JURISDICTION Back to Top
1.The authority citation for 21 CFR part 3 continues to read as follows:
§ 3.6 [Amended]
2.Section 3.6 is amended by removing “(HFG-3), Food and Drug Administration, 15800 Crabbs Branch Way, suite 200, Rockville, MD 20855, 301-427-1934”and by adding in its place “Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5129, Silver Spring, MD 20993-0002, 301-796-8930,”.
Dated: March 17, 2010.
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-6246 Filed 3-22-10; 8:45 am]
BILLING CODE 4160-01-S